IL-6 Triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells.
Diehl, Sean A 1,2; Schmidlin, Heike 2; Nagasawa, Maho 2; Blom, Bianca 2; Spits, Hergen 2,3,4
[Article]
Immunology & Cell Biology.
90(8):802-811, September 2012.
(Format: HTML, PDF)
: Interleukin (IL)-21-producing CD4 T cells are central to humoral immunity. Deciphering the signals that induce IL-21 production in CD4 T cells and those triggered by IL-21 in B cells are, therefore, of importance for understanding the generation of antibody (Ab) responses. Here, we show that IL-6 increased IL-21 production by human CD4 T cells, particularly in those that express the transcriptional regulator B cell lymphoma (BCL)6, which is required in mice for the development of C-X-C chemokine receptor type 5 (CXCR5 ) IL-21-producing T follicular helper (TFH) cells. However, retroviral overexpression of BCL6 in total human CD4 T cells only transiently increased CXCR5, the canonical TFH-defining surface marker. We show here that IL-21 was required for the induction of Ab production by IL-6. In IL-21-treated B cells, signal transducer and activator of transcription (STAT)3 was required for optimal immunoglobulin production and upregulation of PR domain containing 1 (PRDM1 ), the master plasma cell factor. These results, therefore, demonstrate the critical importance of STAT3 activation in B cells during IL-21-driven humoral immunity and suggest that BCL6 expression, although not sufficient, may serve as a platform for the acquisition of a TFH-like phenotype by human CD4 T cells.
(C) 2012 University of Adelaide